Christine Fox
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-01-01–present
-
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Teva Pharmaceutical Industries Ltd (TEVA) | Executive Vice President, US Commercial | $849,231 | $5,895,161 |
| 2024 | Teva Pharmaceutical Industries Ltd (TEVA) | Executive Vice President, US Commercial | $800,000 | $5,218,023 |
| 2023 | Mereo BioPharma Group plc (MREO) | Chief Financial Officer | $378,120 | $1,001,051 |
| 2022 | Mereo BioPharma Group plc (MREO) | Chief Financial Officer | $332,833 | $810,939 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.